Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

24 Jul 2009 11:01

RNS Number : 2364W
Skyepharma PLC
24 July 2009
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

SKYEPHARMA PLC

GB00B3BFNB64

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

YES 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 N/A

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

N/A 

An event changing the breakdown of voting rights

N/A 

Other (please specify):

N/A 

3. Full name of person(s) subject to the notification obligation:

 UBS INVESTMENT BANK

4. Full name of shareholder(s) (if different from 3.):

 UBS AG LONDON BRANCH

5. Date of the transaction and date on which the threshold is crossed or reached:

 22 JULY 2009

6. Date on which issuer notified:

 24 JULY 2009

7. Threshold(s) that is/are crossed or reached:

 6.07%

  

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

 GB00B3BFNB64

 1,147,010

 1,147,010

 1,452,702

 1,452,702

 -

 6.07%

 -

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights

 

 

 

 

 

Nominal

Delta

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 1,452,702

 6.07%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

 

14. Contact name:

 ESTEBAN FRANK/ALEXA KOENIG

15. Contact telephone number:

 +41 44 239 5476

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLKZLBLKDBZBBD
Date   Source Headline
25th Sep 200812:42 pmRNSResult of Bondholders Meeting
24th Sep 20083:24 pmRNSHolding(s) in Company
24th Sep 20083:14 pmRNSHolding(s) in Company
23rd Sep 20086:29 pmRNSHolding(s) in Company
23rd Sep 20086:11 pmRNSHolding(s) in Company
23rd Sep 20083:25 pmRNSRe: Bond Proposals and Open Offer
22nd Sep 200811:09 amRNSVoting Rights and Capital
19th Sep 20084:48 pmRNSSecond Price Monitoring Extn
19th Sep 20084:37 pmRNSPrice Monitoring Extension
19th Sep 200812:39 pmRNSGeneral Meeting Results
18th Sep 20084:41 pmRNSSecond Price Monitoring Extn
18th Sep 20084:36 pmRNSPrice Monitoring Extension
18th Sep 200812:18 pmRNSHolding(s) in Company
18th Sep 200811:43 amRNSHolding(s) in Company
17th Sep 20086:32 pmRNSHolding(s) in Company
17th Sep 200811:49 amRNSHolding(s) in Company
17th Sep 200811:40 amRNSHolding(s) in Company
12th Sep 20089:25 amRNSHolding(s) in Company
4th Sep 200812:23 pmRNSPublication of Prospectus and
4th Sep 200812:09 pmRNSShare Purchase Plan
3rd Sep 20082:09 pmRNSVoting Rights and Capital
2nd Sep 200812:25 pmPRNDisclosure of Short Position - Skyepharma
1st Sep 20086:33 pmRNSBond Consent Solicitation
1st Sep 20086:33 pmRNSPlacing and Open Offer Comple
28th Aug 20087:00 amRNSInterim Results
5th Aug 20084:33 pmRNSShare Purchase Plan
5th Aug 200810:00 amRNSHolding(s) in Company
30th Jul 200812:48 pmRNSHolding(s) in Company
25th Jul 200811:47 amRNSHolding(s) in Company
24th Jul 20084:40 pmRNSSecond Price Monitoring Extn
24th Jul 20084:35 pmRNSPrice Monitoring Extension
22nd Jul 20087:00 amRNSResearch Update
16th Jul 200812:38 pmRNSHolding(s) in Company
9th Jul 20082:40 pmRNSHolding(s) in Company
8th Jul 20087:00 amRNSTrading Update
3rd Jul 20087:00 amRNSResearch Update
2nd Jul 20085:04 pmRNSShare Purchaase Plan
17th Jun 20087:00 amRNSResearch Update
16th Jun 20087:00 amRNSRegulatory Approval
2nd Jun 20085:51 pmRNSShare Purchase Plan
21st May 200812:38 pmRNSAGM Statement
21st May 20087:00 amRNSSuccession Plan
20th May 20087:04 amRNSResearch Update
19th May 20087:00 amRNSInterim Management Statement
2nd May 200810:28 amRNSShare Purchase Plan
30th Apr 20087:00 amRNSResearch Update
24th Apr 200812:04 pmRNSAnnual Information Update
22nd Apr 200810:50 amRNSHolding(s) in Company
22nd Apr 20087:00 amRNSRe Agreement
21st Apr 20084:32 pmRNSAnnual Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.